- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06176313
Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms (MANDALA)
Investigation of the Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
The research employs a pre-test post-test control group design with a randomized controlled semi-experimental approach to determine the impact of education provided for coping with premenstrual syndrome and Mandala activity on premenstrual symptoms.
Research Hypotheses:
H01: Mandala activity is not effective in reducing premenstrual symptoms.
H02: Education provided for coping with premenstrual syndrome is not effective in reducing premenstrual symptoms.
H13: Mandala activity is effective in reducing premenstrual symptoms.
H14: Education provided for coping with premenstrual syndrome is effective in reducing premenstrual symptoms.
H15: Mandala activity is more effective than education provided for coping with premenstrual syndrome in reducing premenstrual symptoms among students with PMS.
Research Groups: Mandala Group, Coping with Premenstrual Symptoms Education Group, and Control Group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In the conducted international and national literature review, it was observed that various methods are utilized in the management of PMS. Still, no study directly examining the effectiveness of Mandala activity on PMS was found. The literature results provided under the title of Mandala indicate that the activities are predominantly focused on behavioral and psychological conditions. Considering the symptoms of PMS, it is assumed that Mandala activity may have an impact on the behavioral and psychological symptoms of PMS. The assumption of how it might affect the physical symptoms of PMS is also supported by studies indicating that art itself has a therapeutic quality and that the creative process helps individuals develop positive coping methods for the physical discomfort they experience.
The research is planned as a pre-test post-test control group design with a randomized controlled semi-experimental approach, aiming to determine the impact of education on coping with premenstrual syndrome and Mandala activity on premenstrual symptoms
Research Hypotheses:
H01: Mandala activity is not effective in reducing premenstrual symptoms.
H02: Education provided for coping with premenstrual syndrome is not effective in reducing premenstrual symptoms.
H13: Mandala activity is effective in reducing premenstrual symptoms.
H14: Education provided for coping with premenstrual syndrome is effective in reducing premenstrual symptoms.
H15: Mandala activity is more effective than education provided for coping with premenstrual syndrome in reducing premenstrual symptoms among students with PMS.
Research Groups: Mandala Group, Coping with Premenstrual Symptoms Education Group, and Control Group.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Merve SEZER YILDIZ, Ph.D. Std.
- Phone Number: 05301789126
- Email: merveyildiz@bilecik.edu.tr
Study Locations
-
-
Merkez
-
Bilecik, Merkez, Turkey, 11100
- Recruiting
- Bilecik Seyh Edebali University
-
Contact:
- MERVE SEZER YILDIZ, Ph.D.Stdnt
- Phone Number: 05301789126
- Email: mervesezer55@gmail.com
-
Contact:
- Email: mervesezer55@gmail.com
-
Principal Investigator:
- MERVE SEZER YILDIZ, Ph.D.Stdnt
-
Sub-Investigator:
- ÖZLEM ÇAĞAN, Assist.Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 18-25 years
- Female students enrolled in the 1st and 2nd years of the Faculty of Health Sciences PMSÖ score of 110 and above
- Regular menstruation in the last six months (between 21-35 days)
- Not using any medication or non-medication methods to cope with PMS symptoms
- Not using contraceptive pills
- Absence of any gynecological diseases (abnormal uterine bleeding, fibroids, ovarian cysts, etc.)
- No diagnosis of psychiatric illness
- Not using any psychiatric medication such as antidepressants
- Absence of any condition that may hinder Mandala drawing
- No previous experience with Mandala education
- Willingness to participate in the study
- Proficiency in speaking and understanding Turkish
Exclusion Criteria: Students who do not meet the criteria mentioned above and are not willing to participate in the study will be excluded.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control Group
|
No intervention will be applied to the control group throughout the research. However, students in this group who cope with premenstrual syndrome using medication or non-medication methods will be monitored during the three-month menstrual cycle. Each student's menstrual cycle in the control group has been recorded in the Excel table. The estimated end of menstruation for each student has been noted.
|
|
Experimental: mandala
|
The Mandala activity lasts approximately 60 minutes. • A calm environment is provided during the Mandala activity, and participants are ensured not to be disturbed by external stimuli or individuals unless they request assistance. Each student's last menstrual date is recorded in an Excel table.
|
|
Experimental: Coping with Premenstrual Symptoms Education Group
|
The education will be conducted through face-to-face interviews in the master's course classroom at the Faculty of Health Sciences at Bilecik Şeyh Edebali University. The education was conducted using PowerPoint presentations projected onto a white smartboard.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the Premenstrual Syndrome Scale (PSS) for mandala pre-test
Time Frame: pre-test
|
The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items.
The total PMSS score is obtained by summing the scores of subscales.
The lowest score that can be obtained on the scale is 44, and the highest score is 220.
Higher scores indicate increased severity of PMS symptoms.
|
pre-test
|
|
the Premenstrual Syndrome Scale (PSS) for education pre-test
Time Frame: pre-test
|
The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items.
The total PMSS score is obtained by summing the scores of subscales.
The lowest score that can be obtained on the scale is 44, and the highest score is 220.
Higher scores indicate increased severity of PMS symptoms.
|
pre-test
|
|
the Premenstrual Syndrome Scale (PSS) for control
Time Frame: pre-test
|
The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items.
The total PMSS score is obtained by summing the scores of subscales.
The lowest score that can be obtained on the scale is 44, and the highest score is 220.
Higher scores indicate increased severity of PMS symptoms.
|
pre-test
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
the Premenstrual Syndrome Scale (PSS) after mandala-1 session
Time Frame: Four days after the first menstrual bleeding.
|
Mandala sessions are conducted with students approximately 7 days before each monthly menstrual bleeding. The sessions are planned in a total of 3 sessions. Four days after each mandala session, students fill out the Premenstrual Syndrome Scale (PSS) form. The result obtained at this time represents the PSS outcome after the 1st Mandala session. Students who scored 110 or above on the Premenstrual Syndrome Scale (PSS) and met the inclusion criteria of the study were randomly assigned to study groups. The scores obtained by the included students on the PSS were considered as the pre-test for the study. The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items. The total PMSS score is obtained by summing the scores of subscales. The lowest score that can be obtained on the scale is 44, and the highest score is 220. Higher scores indicate increased severity of PMS symptoms. |
Four days after the first menstrual bleeding.
|
|
the Premenstrual Syndrome Scale (PSS) after mandala-2 session
Time Frame: Four days after the second menstrual bleeding."
|
Mandala sessions are conducted with students approximately 7 days before each monthly menstrual bleeding. The sessions are planned in a total of 3 sessions. Four days after each mandala session, students fill out the Premenstrual Syndrome Scale (PSS) form. The result obtained at this time represents the PSS outcome after the 2st Mandala session. Students who scored 110 or above on the Premenstrual Syndrome Scale (PSS) and met the inclusion criteria of the study were randomly assigned to study groups. The scores obtained by the included students on the PSS were considered as the pre-test for the study. The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items. The total PMSS score is obtained by summing the scores of subscales. The lowest score that can be obtained on the scale is 44, and the highest score is 220. Higher scores indicate increased severity of PMS symptoms. |
Four days after the second menstrual bleeding."
|
|
the Premenstrual Syndrome Scale (PSS) after mandala-3 session
Time Frame: Four days after the third menstrual bleeding.
|
Mandala sessions are conducted with students approximately 7 days before each monthly menstrual bleeding. The sessions are planned in a total of 3 sessions. Four days after each mandala session, students fill out the Premenstrual Syndrome Scale (PSS) form. The result obtained at this time represents the PSS outcome after the 3st Mandala session. Students who scored 110 or above on the Premenstrual Syndrome Scale (PSS) and met the inclusion criteria of the study were randomly assigned to study groups. The scores obtained by the included students on the PSS were considered as the pre-test for the study. The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items. The total PMSS score is obtained by summing the scores of subscales. The lowest score that can be obtained on the scale is 44, and the highest score is 220. Higher scores indicate increased severity of PMS symptoms. |
Four days after the third menstrual bleeding.
|
|
Premenstrual Syndrome Scale (PMSS) education final test
Time Frame: After the third menstrual bleeding, four days later.
|
Premenstrual Syndrome Scale (PMSS): PMSS consists of 44 items.
The total PMSS score is obtained by summing the scores of subscales.
The lowest score that can be obtained on the scale is 44, and the highest score is 220.
Higher scores indicate increased severity of PMS symptoms.
|
After the third menstrual bleeding, four days later.
|
|
Premenstrual Syndrome Scale (PMSS) control final test
Time Frame: After the third menstrual bleeding, four days later.
|
The Premenstrual Syndrome Scale (PMSS): The PMSS consists of 44 items.
The total PMSS score is obtained by summing the scores of subscales.
The lowest score that can be obtained on the scale is 44, and the highest score is 220.
Higher scores indicate increased severity of PMS symptoms.
|
After the third menstrual bleeding, four days later.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Merve SEZER YILDIZ, Ph.D. Student, Bilecik Seyh Edebali University
- Study Director: Özlem ÇAĞAN, Assist. Professor, Eskisehir Osmangazi University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- merve-sezer-yildiz-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premenstrual Syndrome
-
Haleema SadiaCompletedPremenstrual Syndrome-PMSPakistan
-
Esra ÖZERKTO Karatay UniversityCompletedPremenstrual Syndrome-PMSTurkey
-
University of Health Sciences LahoreActive, not recruitingPremenstrual Syndrome-PMSPakistan
-
Shaare Zedek Medical CenterUnknownPremenstrual Syndrome-PMS
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)RecruitingMenstrual Cycle | Premenstrual Syndrome | Premenstrual Syndrome-PMS | PMDD | Premenstrual Dysphoric Disorder (PMDD)United States
-
Cairo UniversityNot yet recruitingPremenstrual Tension
-
Cairo UniversityNot yet recruitingPremenstrual Pain
-
Activ'insideActive, not recruitingPremenstrual Syndrome-PMSItaly
-
Izmir Democracy UniversityEnrolling by invitationPremenstrual Syndrome-PMSTurkey
-
Philipps University Marburg Medical CenterLinkoeping UniversityCompletedPremenstrual Syndrome (PMS)Germany
Clinical Trials on Mandala Group
-
Tokat Gaziosmanpasa UniversityCompletedAnxiety | Well-being | Nursing StudentsTurkey (Türkiye)
-
Cukurova UniversityCompletedPain | AnxietyTurkey
-
Akdeniz UniversityKoç UniversityCompleted
-
Munzur UniversityCompletedGynecologic Cancer | ART | Life SatisfactionTurkey
-
Istanbul Sabahattin Zaim UniversityCompletedHemodialysis PatientsTurkey
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Fatma Keskin TöreCompletedPregnancy | State AnxietyTurkey (Türkiye)
-
Agri Ibrahim Cecen UniversityCompletedEffects of Nada Yoga Music and Mandala Coloring During Labor on Pain, Anxiety, and Maternal OutcomesChildbirth | Labor ProcessTurkey (Türkiye)
-
Marmara UniversityCompletedCoronary Artery Disease | AnxietyTurkey
-
Kahramanmaras Sutcu Imam UniversityCompletedMenopause | Self Esteem | Women | Sexual Activity | Menopause SymptomsTurkey (Türkiye)